BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18486579)

  • 21. Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device.
    Pesonen E; Thilen U; Sandström S; Arheden H; Koul B; Olsson SE; Wilson RF; Toher C; Bank A; Bass J
    Scand Cardiovasc J; 2000 Aug; 34(4):446-8. PubMed ID: 10983682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular septal defect closure in a small children with the Amplatzer Duct Occluder II.
    El Tahlawi M; Kammache I; Fraisse A
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):268-71. PubMed ID: 21290557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
    Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
    Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closure of a muscular ventricular septal defect using the Amplatzer ventricular occluder.
    Dehghani M; Sharifkazemi MB; Aslani A; Hoseini E; Samin MM
    Arch Iran Med; 2007 Oct; 10(4):543-5. PubMed ID: 17903065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent foramen ovale and ventricular septal defect closure.
    Wahl A; Meier B
    Heart; 2009 Jan; 95(1):70-82. PubMed ID: 19047442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Device closure of residual ventricular septal defect after repair of tetralogy of fallot using the amplatzer duct occluder.
    Vaidyanathan B; Kannan BR; Kumar RK
    Indian Heart J; 2005; 57(2):164-6. PubMed ID: 16013358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter treatment of perimembranous ventricular septal defect, secundum atrial septal defect and patent ductus arteriosus in a child.
    Butera G; Piazza L; Hijazi Z; Chessa M; Carminati M
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):775-8. PubMed ID: 17001241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Cobra malformation' of an Amplatzer device during percutaneous closure of a ventricular septal defect.
    Schrale RG; Mitchell AR; Wilson N
    Eur Heart J; 2007 Mar; 28(6):698. PubMed ID: 17043062
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient renal failure due to hemolysis following transcatheter closure of a muscular VSD using an Amplatzer muscular VSD occluder.
    Spence MS; Thomson JD; Weber N; Qureshi SA
    Catheter Cardiovasc Interv; 2006 May; 67(5):663-7. PubMed ID: 16575921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2.
    Velasco-Sanchez D; Tzikas A; Ibrahim R; Miró J
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):474-9. PubMed ID: 22431366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic effect and safety of transcatheter occlusion of ventricular septal defects in 50 patients].
    Hu DJ; Li CC; Pu XQ; Zheng ZF; Zhao YC; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):587-9. PubMed ID: 16320595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unruptured right sinus of Valsalva aneurysm in a Maltese dog: a case report.
    Uemura A; Tanaka R; Nakata TM; Namiki R; Tanaka T; Matsuura K; Yoshida T
    J Vet Sci; 2019 May; 20(3):e20. PubMed ID: 31161738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter closure of iatrogenic perimembranous ventricular septal defect after aortic valve and ascending aorta replacement using an Amplatzer membranous ventricular septal occluder.
    Chojnicki M; Sukiennik A; Anisimowicz L; Swiatkiewicz I; Pawliszak W
    Cardiol J; 2008; 15(2):189-91. PubMed ID: 18651405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous closure of post-traumatic and congenital muscular ventricular septal defects with the Amplatzer Muscular VSD Occluder.
    Szkutnik M; Kusa J; Białkowski J
    Kardiol Pol; 2008 Jul; 66(7):715-20; discussion 721. PubMed ID: 18690562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Percutaneous closure of a mid-muscular residual ventricular septal defect using the Amplatzer(TM) device].
    Fábrega Sabaté J; Rodés-Cabau J; Piéchaud JF; Albert Brotons D; Casaldáliga Ferrer J; Gonçalves A; Girona Comas J
    An Esp Pediatr; 2002 Jul; 57(1):66-9. PubMed ID: 12139896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter closure of muscular ventricular septal defect using the Amplatzer devices.
    Djer MM; Latiff HA; Alwi M; Samion H; Kandavello G
    Heart Lung Circ; 2006 Feb; 15(1):12-7. PubMed ID: 16473785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complications of transcatheter interventional occlusion of ventricular septal defects].
    Zhang YS; Li H; Liu JP; Dai ZX; Wang L; Zhang J; Li J; Wang XY
    Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):35-8. PubMed ID: 15796806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical correction of a partial atrioventricular septal defect with a ventricular septal defect in a dog.
    Akiyama M; Tanaka R; Maruo K; Yamane Y
    J Am Anim Hosp Assoc; 2005; 41(2):137-43. PubMed ID: 15767659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous closure of ventricular septal defect associated with tunnel-shaped aneurysm using the Amplatzer duct occluder.
    Dilawar M; Numan M; El-Sisi A; Gendi SM; Ahmad Z
    Pediatr Cardiol; 2008 Mar; 29(2):366-70. PubMed ID: 17952490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry.
    Holzer R; Balzer D; Amin Z; Ruiz CE; Feinstein J; Bass J; Vance M; Cao QL; Hijazi ZM
    Catheter Cardiovasc Interv; 2004 Feb; 61(2):196-201. PubMed ID: 14755811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.